ArticleMethods in molecular biology (Clifton, N.J.)2026
Cryopreserving Small Volumes of Red Blood Cells Using the High Glycerol Method.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cryopreservation of red blood cells (RBCs) plays a critical role in blood inventory management by enabling long-term frozen storage of rare blood types. This process requires the addition of glycerol, a cryoprotectant that mitigates cellular damage caused by ice crystal formation during freezing and thawing. A high glycerol method (HGM) is commonly used, which requires an approximate concentration of 40% glycerol and enables slow freezing rates (1-3°C/min) and extended storage in low-temperature freezers (≤-65°C). While automated cell processing systems have been developed for the glycerolization and deglycerolization of full-size RBC units for transfusion, there is no such technology for the small-scale cryopreservation of RBC aliquots. This chapter presents a high-recovery, small-scale model that mirrors current automated cell processing systems that employ the HGM for cryopreservation of RBCs. This technique is valuable for (1) research studies, particularly for investigations on cryopreservation of rare donor phenotypes or investigating novel cryoprotectants, (2) to provide control or reagent cells for antibody identification or compatibility testing, or (3) any other applications requiring small volumes of functional and intact RBCs.
Indexed as
Identifiers
42732515What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.